Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001567619-21-010746

Options or other derivatives

  • Director acquired 22,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tomasello Shawn · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-17 Grant or award : show line 1 in the form Stock Option (Right to Buy) +22,500 22,500 D
Loading xslF345X03/doc1.xml…